HMGB1 mediates microbiome-immune axis dysregulation underlying reduced neutralization capacity in obesity-related post-acute sequelae of SARS-CoV-2. This evidence concerns the gene HMGB1 and obesity due to melanocortin 4 receptor deficiency.